European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms

doi:10.5315/wjh.v4.i3.16

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16583)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-20) series, Tables (1-12) series.

Item

Count

PDF

841

WORD

472

HTML

9086

Figures (1-20)

652

Tables (1-12)

341

Sum=11392

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

887

Download

1815

Sum=2702

Publishing Process of This Article

Item

Count

Browse

1240

Download

1249

Sum=2489

Aug 6, 2015 (publication date) through Sep 20, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hematol. Aug 6, 2015; 4(3): 16-53
Published online Aug 6, 2015. doi: 10.5315/wjh.v4.i3.16

Full Size Figure Download Figure

Figure 20 World Health Organization-clinical molecular and pathological myeloproliferative neoplasms classification and transitional states. ET: Essential thrombocythemia; PV: Polycythemia vera; MGM: Megakaryocytic granulocytic myeloproliferation; IE: Idiopathic erythrocythemia; RF: Reticulin fibrosis; MF: Myelofibrosis; RCF: Reticulin collagen fibrosis; CALR: Calreticulin; PMGM: Primary megakaryocytic granulocytic myeloproliferation.

Citation: Michiels JJ, Valster F, Wielenga J, Schelfout K, Raeve HD. European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms. World J Hematol 2015; 4(3): 16-53
URL: https://www.wjgnet.com/2218-6204/full/v4/i3/16.htm
DOI: https://dx.doi.org/10.5315/wjh.v4.i3.16